The PharmaTimes Communications Team of the Year competition is the only pharma industry award that tests the competencies and potential of communications agency teams, benchmarking talent agency side – and as such, entry is a must.
AstraZeneca’s Tagrisso has been approved in the US as a first-line treatment for patients with metastatic non-small-cell lung cancer whose tumours have epidermal growth factor receptor (EGFR) mutations.
Having seen some outstanding performances from individuals and teams at the PharmaTimes International Clinical Researcher of the Year finals days, the 2018 PharmaTimes International Clinical Researcher of the Year Awards Ceremony looks set to be one of the best yet.
MPs have criticised the government’s slow response to last year’s WannaCry attack on the NHS, and warn there is much work to be done to improve cyber security if damage from the next attack is to be minimised.
Rigel Pharmaceuticals has bagged its first FDA approval, with a green light to market Tavalisse for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have failed to respond to previous treatment.